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Chronic CT- 1 treatment impairs stimulation of glucose transport in 
cardiomyocytes
Mohamed Asrih [Orateur], I. Papageorgiou, Christophe Montessuit
Fondation pour la recherche Medicale, cardiologie, Genève, Suisse
Aims: Cardiotrophin- 1 (CT- 1), a member of Interleukine- 6 (IL- 6) family, 
causes insulin resistance in adipocytes. However its effect on glucose meta-
bolism in the heart remains unknown. Thus we proposed to test whether CT- 1 
induces insulin resistance in cultured cardiomyocytes.
Methods: Rat cardiomyocytes were cultured in presence or absence of 1nM 
CT- 1. Thereafter glucose transport was measured in response to insulin or 
Oligomycin, a mitochondrial ATP synthase inhibitor, used as a surrogate of 
metabolic stress. Intracellular signaling triggered by glucose transport stimuli 
was analyzed by Western- Blot.
Results: Cardiomyocytes stimulated with increasing dose of insulin exhi-
bited a dose response of glucose transport However, when treated with CT- 1 
the response of relative glucose transport was markedly, indicating reduction 
in insulin responsiveness. CT- 1 also reduced oligomycin- stimulated glucose 
transport. By Western- Blot we found lower phosphorylation of the signaling 
intermediates IR, Akt, and AS160 in CT- 1 treated cardiomyocytes.
Conclusion: Chronic exposure of cardiomyocytes to CT- 1 leads to a loss in 
the À exibility of glucose metabolism, by mechanisms that may involve a role 
for SOCS3 and STAT5, known insulin resistance inducers.
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AMPK exerts an insulin- sensitizing effect on cardiac glucose uptake by 
multiple molecular mechanisms
Julien Auquier [Orateur], Audrey Ginion, Louis Hue, Jean- Louis 
Vanoverschelde, Christophe Beauloye, Sandrine Horman, Luc Bertrand
Université catholique de Louvain, IREC, Pôle de Recherche Cardio-
vasculaire, Bruxelles, Belgique
Insulin- resistant cardiomyocytes are characterized by a decreased ability 
of insulin to stimulate Akt phosphorylation and glucose uptake. We have pre-
viously shown that the activation of AMPK by phenformin restores insulin- 
sensitivity in insulin- resistant cardiomyocytes. The aim of our present work 
is to understand by which molecular mechanisms AMPK exerts its insulin 
sensitizing effect. In this study we focused on the mTOR/p70S6K pathway. 
Indeed, this pathway is known to reduce insulin signaling via a negative fee-
dback loop involving serine phosphorylation of IRS- 1. As AMPK inhibits 
p70S6K, it is commonly accepted that AMPK increased insulin- sensitivity 
by inhibiting this p70S6K- mediated negative feedback loop. To con¿ rm this 
hypothesis, we tested if rapamycin, a speci¿ c inhibitor of the mTOR/p70S6K 
pathway, was able to mimic AMPK activators. Similarly to phenformin, rapa-
mycin increased the insulin- dependent phosphorylation of Akt and its subs-
trate AS160, involved in the regulation of glucose uptake. Despite the ability 
of rapamycin to induce this Akt/AS160 over- phosphorylation, rapamycin 
was not able to restore the insulin- dependent stimulation of glucose uptake 
like phenformin did. In view of this result showing that the inhibition of the 
mTOR/p70S6K pathway had no effect on insulin- stimulated glucose uptake, 
we used leucine known to activate the mTOR/p70S6K pathway. The leucine- 
dependent p70S6K over- phosphorylation induced the stimulation of the 
negative feedback loop and the inhibition of both PKB and AS160 phospho-
rylation but did not change the insulin- stimulated glucose uptake. In conclu-
sion, we showed a discrepancy between the regulation of the PKB/AS160 
pathway and of glucose uptake in cardiomyocytes. Moreover, the inhibition 
of the p70S6K/IRS- 1- mediated negative feedback loop is not suf¿ cient to 
explain the insulin- sensitizing effect of AMPK on glucose uptake demons-
trating that AMPK exerts its insulin- sensitizing effect by multiple molecular 
mechanisms.
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Angiotensin type II receptor (AT2R) increases reactive oxygen species 
 levels and COX- 2 derived vasoconstrictor prostanoids in diabetic mice 
resistance arteries
Marc- Antoine Begorre [Orateur], Emilie Vessieres, Laurent Loufrani, 
Celine Fassot- Lucht, Daniel Henrion
Laboratoire de Biologie Neurovasculaire et Mitochondriale Intégrée (www.
bnmi.fr), UMR CNRS 6214 INSERM U 1083, Angers, France
Background and objectives: The renin- angiotensin system (RAS) is a key 
regulator of cardiovascular physiopathology. The effects of angiotensin II are 
mainly mediated by two receptors: Angiotensin type 1 (AT1R) and type 2 (AT2R) 
receptors. AT1R is well known for its hypertensive and trophic effects leading 
to most cardiovascular diseases. AT2R is described as opposing the effects of 
AT1R, with vasodilatory and antitrophic properties. AT2R opposes angiotensin 
II- dependent hypertension in female rats, not in males. We have also previously 
shown (Hypertension. 2010;55:339- 44) that AT2R stimulation in mesenteric arte-
ries from Zucker diabetic fatty (ZDF) rats increases reactive oxygen species 
(ROS) level and activates a COX- 2- dependent production of thromboxane A2. 
Thus we aimed to determine the role of AT2R in endothelium- mediated dilation 
in a mouse model of diabetes using both male and female animals.
Methods: Male and female wild- type (WT) and AT2R KO mice were 
injected with Streptozotocin (150mg/kg) in order to induce diabetes. After 
45 days, mice were sacri¿ ced and mesenteric resistance arteries mounted on 
a wire myograph.
Results: Acetylcholine induced a concentration- dependent relaxation. 
Diabetes induced a reduction in relaxation from 80±5% to 71±9% in WT 
female but not signi¿ cantly in WT male. Blockade of AT2R (PD123319), 
ROS reduction (tempol + catalase) or COX2 inhibition (CAY10404) improved 
signi¿ cantly relaxation in diabetic male and female mice arteries. In mesen-
teric arteries from diabetic AT2R KO mice, acetylcholine- mediated relaxation 
was equivalent to that in non- diabetic mice in both male and female animals. 
Phenylephrine- mediated contraction and endothelium- independent relaxation 
to sodium nitroprusside were not affected.
Conclusions and perspectives: AT2R opposes endothelium- dependent 
relaxation in a mouse model of type 1 diabetes, through the activation of ROS 
and COX2- derived prostanoid(s) without major difference between male and 
female mice.
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Gender differences in type 2 diabetes: experimental study in the type 2 
diabetic Goto- Kakizaki (GK) rat heart
Martine Desrois [Orateur] (1), Carole Lan (1), Christiane Dalmasso (1), 
Bernard Portha (2), Danielle Bailbé (2), Patrick J Cozzone (1), Monique 
Bernard (1)
(1) CRMBM, UMR CNRS 6612, Marseille Cedex 05, France - 
(2) Laboratoire de Biologie et Pathologie du Pancréas Endocrine (B2PE), 
Unité BFA, Paris Cedex 13, France
Background: Aging and diabetes in women increase their susceptibility to 
myocardial ischemic injury but the molecular mechanisms involved are not 
well understood. Consequently, we have investigated the effect of gender on 
cardiac function, energy metabolism, endothelial function and NO pathway in 
the aging type 2 diabetic Goto- Kakizaki (GK) rat heart. 
Materials and Methods: Age- matched (8 months) Control Wistar (male 
n=11, female n=9) and GK (male n=11, female n=12) isolated rat hearts were 
perfused during 28min with a physiological Krebs- Henseleit buffer contai-
ning 0.4mM palmitate, 3% albumin, 11mM glucose, 3U/L insulin, 0.8mM 
lactate and 0.2mM pyruvate before freeze- clamping for biochemical assays. 
High energy phosphate compounds and intracellular pH (pHi) were followed 
using 31P magnetic resonance spectroscopy with simultaneous measurement 
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of contractile function. NO pathway was studied by total nitrate concentra-
tion (NOx) as well as total level and phosphorylation of eNOS and Akt. In 
parallel, endothelium- dependent and independent vasodilatations were mea-
sured in other hearts (male Control n=8, male GK n=8, female Control n=10, 
female GK n=11), using 5- hydroxytryptamine and papaverine to assess endo-
thelial and smooth muscle functions. Results: Phosphocreatine, ATP, PME and 
Pi were not signi¿ cantly different in Control and diabetic groups. Total pool of 
creatine (creatine and phosphocreatine) and total adenine nucleotides content 
were similar in all groups. Myocardial function was signi¿ cantly impaired 
in male and female diabetic versus Control groups (p<0.05). Endothelium- 
dependent and independent vasodilatations were not different in male Control 
and GK rat hearts. By contrast, endothelium- dependent and independent vaso-
dilatations were signi¿ cantly impaired in female GK compared with male GK 
(p<0.05) and female Control (p<0.05) rat hearts. Conclusion: We reported 
here an impaired endothelial and smooth muscle functions but normal energy 
metabolism in the female GK rat hearts. These results could be related to 
higher risk of cardiovascular disorders in type 2 diabetic female.
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Aldosterone protects the insulin- activated AKT pathway in heart of 
diabetic type 2 mice
Loubina Fazal [Orateur], Feriel Azibani, Nicolas Bihry, Régine Merval, 
Evelyne Polidano, Jane- Lise Samuel, Claude Delcayre
INSERM U 942, Hôpital Lariboisière, Paris, France
Introduction: The pathogenesis of diabetic cardiomyopathy is not fully elu-
cidated. Numerous factors may contribute to the development of heart failure 
in a diabetic context, including the scarcity of microvasculature and neuro-
humoral dysregulation, particularly the renin- angiotensin- aldosterone- system. 
We have previously shown that a modest increase of intracardiac aldosterone 
prevents the development of cardiomyopathy in mice with type 1 diabetes, 
possibly through a prevention of cardiac capillary dropout (Messaoudi et al, 
Faseb J 2009). This study aimed to determine the pathophysiological effects 
and to study transduction pathways of insulin in the case of a cardiac hyperal-
dosteronism with or without type 2 diabetes (T2D).
Methods: 3 week- old mice overexpressing aldosterone synthase (AS), n=9, 
and their wild- type (WT) n=5 were fed a high fat, high sucrose diet (HFHSD) 
or a standard diet ad libitum. After 4 months of diet, glucose and insulin tole-
rance tests were performed. Mice were sacri¿ ced and tissue samples were 
used for RT- PCR. In addition, to analyze the signaling pathways dependent 
of the insulin receptor and insulin growth factor receptor, some of these mice 
(n=5)received a dose of insulin(1UI/kg bw)30 minutes before the sacri¿ ce.
Results: After 4 months of HFHSD, both WT- D and AS- D mice had hyper-
glycemia(+55%,56%, P<0.05 vs WT and AS, respectively) and body overweight 
(+20%,P<0.001;+30%,P<0.05 vs WT and AS, respectively). Both WT and AS dis-
played glucose intolerance and insulin resistance. Surprisingly, VEGFa and insulin 
receptor substrate 1(IRS1) mRNAs were upregulated in AS- D mice (+44%, 
P<0.05 vs WT- D; +20% P<0.05 vs AS). Besides, NOS3 (Nitric Oxide Synthase 
3) and IRS2 were increased in both diabetic groups. In basal conditions, as shown 
by the decreased p- AKT/AKT ratio on Western blot the AKT kinase activity was 
decreased in hearts of WT- D mice only. Interestingly, acute stimulation of AKT by 
insulin revealed an increase of the p- AKT/AKT ratio in AS- D only. 
Conclusion: The results indicate that in mice developing T2D the AKT 
signaling pathway in heart could be stimulated by insulin only when cardiac 
hyperaldosteronism was present. This aldosterone- dependent activation of the 
AKT pathway might play a role in the induction of VEGFa in heart.
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Effects of a multidisciplinary rehabilitation program in diabetics pa-
tients with peripheral arterial disease
Céline Freyssin [Orateur] (1), Fabrice Prieur (2), Chantal Verkindt (3), 
Philippe Benaich (1), Sébastien Maunier (1), Philippe Blanc (1)
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Orléans, France - (3) Laboratoire DIMPS, EA4075, Université Réunion, 
France, Le Tampon, France
Aim: Peripheral arterial disease (PAD) is a peripheral arterial complica-
tion resulting in a decrease in the arterial calibre. Despite the importance of 
its prevalence and morbid- mortality, PAD remains too often underestimated 
and is insuf¿ ciently managed. Rehabilitation is recommended as a reference 
treatment during PAD. This study examines the impact of a multidisciplinary 
rehabilitation program on some vascular and hemodynamic parameters, on 
glycemic control and on levels of anxiety and depression in PAD patients.
Methods: 58 patients with diabetic and peripheral arterial disease (PAD) 
were enrolled in a 6 week tailored multidisciplinary cardiac rehabilitation 
program. This program includes medical supervision, educational sessions 
(7 hours per week) and adapted physical activity (13 hours per week).
Glycated haemoglobin, fasting blood glucose, small artery elasticity index, 
ankle brachial index, distance performed during a 6min walk test (6MWT), per-
formance during progressive exercise on treadmill and the level of anxiety and 
depression were measured before and at the end of their cardiac rehabilitation.
Results: The cardiac rehabilitation program increased signi¿ cantly distance 
performed at the 6MWT (p=0.038), performance during the progressive exer-
cise (p=0.005), the ankle brachial index right (p=0.003) and left (p=0.001), 
small artery elasticity index (p<0.001), and decreased signi¿ cantly glycated 
haemoglobin (p=0.008), fasting blood glucose (p=0.003), level of anxiety 
(p<0.001) and the level of depression (p=0.002).
Conclusion: The cardiac rehabilitation program had a signi¿ cant positive 
effect on some vascular and hemodynamic parameters, the control of gly-
caemia and the levels of anxiety and depression of PAD patients. These para-
meters are considered prognosis. In view of our results and recent data from 
the literature, we can think that exercise in rehabilitation could be involved in 
development of collateral circulation.
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The ef¿ cacy of treatment with alpha- lipoic acid in the evolution of met-
abolic syndrome in rats
Steliana Ghibu [Orateur] (1), Claudiu Morgovan (2), Oliviu Vostinaru (1), 
Cristina Mogosan (1), Cristina Craciun (3), Maria Dronca (4)
(1) Université de Médicine et Pharmacie, Département de Pharmacologie, 
Cluj Napoca, Roumanie - (2) Université “Vasile Goldis”, Arad, Roumanie - 
(3) Université de Médicine et Pharmacie, Département de Biochimie phar-
maceutique et laboratoire clinique, Cluj Napoca, Roumanie - (4) Université 
de Médicine et Pharmacie, Département de Biochimie médicale, Cluj 
Napoca, Roumanie
Objectives: The metabolic syndrome (MS) is frequently met nowadays, 
being characterized by a perturbation of glucides’ and lipids’ metabolism in 
association with free radicals’ synthesis and an oxidative stress installation. 
Alpha- lipoic acid (AL) is an endogenous antioxidant which is able to sca-
venge free radicals, chelate transition metals (iron and copper) or regenerate the 
reduced forms of the same antioxidants (vitamin E, vitamin C and glutathione). 
The purpose of this study was to monitor the bene¿ ts provided by an antioxi-
dant therapy with alpha- lipoic acid in rats which present symptoms of MS. 
Methods: 48 male Sprague- Dawley rats were randomized into two series: 
rats fed for 3 months with standard chow (Control) or with standard chow sup-
plemented with fructose (60%). In each series, a group of rats was treated intra-
peritoneally during 14 days/month with NaCl 0.9% and another group with 
50mg/kg/day AL. Throughout the treatment the body weight, glycaemia and 
systolic blood pressure were being monitored. At the end of the 3 months, we 
assessed: 1) plasmatic lipid pro¿ le, 2) products of lipid peroxidation: malon-
dialdehide (MDA) and 3) the endogenous antioxidant status: total glutathione. 
Results: The glycaemia and the systolic blood pressure had signi¿ cantly 
(p<0.05) increased in the fructose- fed rats since the 2 weeks of diet. After 
3 months of fructose- enriched diet, the level of triglycerides (x5.35 times) 
and LDL- Cholesterol (x7.82 times) was signi¿ cantly (p<0.001) higher as com-
pared to the Control group, without inÀ uencing the rats’ body weight. Also, 
the level of MDA and oxidized glutathione (GSSG) had signi¿ cantly (p<0.05) 
increased. At the same time, in fructose- fed rats treated with AL, the MS charac-
teristic parameters were reduced: glycaemia (119.92±2.43 vs 126.33±1.91mg/
dl, p<0.05), systolic blood pressure (123.95±0.95 vs 132.98±1.15mmHg, 
p<0.01), triglycerides (151.73±8.32 vs 331.20±23.15mg/ dl, p<0.001) and 
LDL- Cholesterol (35.08±4.70 vs 81.00±18.33mg/dl, p<0.01). A decrease in 
lipid and glutathione oxidation was also noted. 
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Conclusions: In our experimental conditions, the MS disturbances and the 
oxidative stress associated were signi¿ cantly ameliorated by an antioxidant 
therapy with alpha- lipoic acid.
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Physiological concentration of glutamine increases exogenous fatty acid 
utilization in the ex vivo working heart: Role of the hexosamine biosyn-
thetic pathway
Benjamin Lauzier [Orateur] (1), Fanny Vaillant (1), Bertrand Bouchard (1), 
Roselle Gélinas (1), Julie Thompson Legault (1), Vernon Dolinsky (2), 
Jason Dyck (2), John Chatham (3), Christine Des Rosiers (1)
(1) Institut de Cardiologie de Montréal, Laboratoire de Métabolisme 
Intermediaire, Montreal, Canada - (2) Cardiovascular Research Center, 
Department of Pediatrics, Universtiy of Alberta, Edmonton, Canada 
- (3) Division of Cardiovascular Disease, Departement of Medicine, 
Birmingham, Etats- Unis
Glutamine (GLN) is the most abundant amino acid in the plasma, and has 
been shown to exert cardiac effects but the underlying mechanisms remained 
unclear. We assessed the metabolic effects of a physiological concentration of 
GLN and tested the involvement of the following mechanism: i) anaplerosis 
(ANA) via conversion to citric acid cycle (CAC) intermediates or ii) activation 
of the hexosamine biosynthetic pathway (HBP). Working rat hearts were per-
fused with physiological concentrations of 13C- labeled glucose and a long chain 
fatty acid (LCFA; oleate) with or without 0.5mM GLN under various condi-
tions. We measured include functional and metabolic À ux as well as tissue levels 
of CAC intermediates. GLN had little impact in working hearts, but reversed 
the decreased cardiac output (65%) induced by restricted CHO supply (without 
pyruvate and insulin to enhance demand on GLN ANA). At the metabolic level, 
our data do not support a role of GLN as ANA substrate: i) measured tissue 
levels of CAC intermediates, which were decreased (control) or unaffected (low 
CHO) by GLN addition, or ii) the absence of 13C- labeling of these CAC inter-
mediates when hearts were perfused with [U- 13C]GLN. GLN addition increased 
the contribution of oleate β- oxidation to acetyl- CoA (+51%) and to triglyceride 
formation (+180%) albeit only under the control condition. This effect cannot be 
explained by mechanisms regulating β- oxidation, namely level of malonyl- CoA, 
acetyl- CoA carboxylase or AMP kinase (by Western). The effect on oleate oxida-
tion was reversed by the addition of 20 μM azaserine an HBP inhibitor. In hearts 
from spontaneously hypertensive rats, (with a defective CD36 - a LCFA trans-
porter (restricted exogenous LCFA utilization), GLN addition did not increase 
exogenous oleate utilization. These results demonstrate that a physiological 
concentration of glutamine can modulate energy substrate selection in the heart. 
The metabolic effect appears to involve the HBP and CD36 rather than ANA.
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LDL- cholesterol lowering effect of a dietary supplement with plant ex-
tracts on moderate hypercholesterolemia subjects: a randomized con-
trolled study
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Aytré, France - (2) INRA, UMR1260 « Nutriments Lipidiques et Prévention 
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Département de Biochimie, Avignon Cedex 9, France - (4) INSERM- APHM, 
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Purpose: Red Yeast Rice (RYR), Sugar Cane- derived Policosanols (SCdP) 
and Artichoke Leaf Extracts (ALEs) are currently incorporated alone or 
in combination into dietary supplements for their potential Low- density- 
Lipoprotein- Cholesterol (LDL- C) lowering effects. To date, there is no infor-
mation supporting the ef¿ cacy of this association on the reduction of LDL- C. 
The main objective of this study was to investigate the effects of a new dietary 
supplement with RYR, SCdP and ALEs on LDL- C on moderate untreated 
hypercholesterolemic subjects. The speci¿ city of this supplement is the use of 
low doses of monacolins and ALEs to limit adverse effects. 
Methods: It is a mono- centric, double- blind, placebo- controlled, parallel 
group study. Thirty- nine hypercholesterolemic subjects were randomly assi-
gned to 2 groups, one consuming a Dietary Supplement (DS) containing RYR, 
SCdP and ALEs and the other consuming a placebo, during 16 weeks. Plasma 
levels of lipids (LDL- C, Total Cholesterol (TC), high- density- lipoprotein 
cholesterol, triacylglycerols (TG)), vitamins C and E, total polyphenols and 
malondialdehyde were determined at baseline and after 4, 8, 12 and 16 weeks 
of supplementation. 
Results: LDL- C and TC were signi¿ cantly reduced by respectively 
21.44±9.75% and 14.05±8.12% at week 16 compared to baseline in DS group. 
Similar results were obtained already at weeks 4, 8 and 12. TG were decreased 
signi¿ cantly at week 16 (- 12.16±25.37%) in DS group. For the vitamin E/TC 
ratio, a meaningful difference was observed between groups at week 16. Other 
parameters were not modi¿ ed substantially. Compliance was high (>91%) and 
products were well tolerated.
Conclusions: Daily consumption of a dietary supplement with a combi-
nation of RYR, SCdP and ALEs decreased signi¿ cantly LDL- C and TC and 
is therefore an interesting and convenient aid in managing mild to moderate 
hypercholesterolemia.
Trial registration: ClinicalTrials. gov, www.clinicaltrials.gov, 
NCT01354327.
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